New Drug-Coated membrane targets sarcoma after surgery
Disease control
Completed
This early-stage trial tested a special membrane loaded with the drug SN-38 in 21 people with recurrent or advanced retroperitoneal sarcoma. The membrane was placed in the surgical area after tumor removal to see if it is safe and tolerable. The goal is to find the right dose and…
Phase: PHASE1 • Sponsor: CEBIOTEX • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC